<DOC>
	<DOCNO>NCT02449369</DOCNO>
	<brief_summary>This prospective , three-arm , randomize , open-label trial determine new pain control protocol include regular dose intravenous acetaminophen orphenadrine 48 hour total knee surgery reduces need opioid pain medication reduces average pain score .</brief_summary>
	<brief_title>Intra-Venous Acetaminophen Muscle Relaxants After Total Knee</brief_title>
	<detailed_description>This research prospective , three-arm , randomize , open-label trial ass opioid use patient report outcomes 48 hour regular IV acetaminophen muscle relaxant ( IVAM ) orphenadrine administration follow total knee replacement surgery . 180 patient ( 60 arm ) randomize receive standard group treatment , IVAM group treatment , control grouptreatment . Standard Group Treatment : include peripheral nerve single injection catheter infusion ( 48 hour ) request surgeon ; preoperative ( single dose ) intravenous acetaminophen ( 1000 mg ) orphenadrine ( 60 mg ) ; intraoperative spinal anesthesia general anesthesia determine anesthesia attend physician ; postoperative oral oxycodone ( 5 mg ) acetaminophen ( 325 mg ) ( PRN dose ) , oral orphenadrine ( 100 mg ) every 12 hour 3 dos , intravenous hydromorphone ( PRN dose ) breakthrough pain . Control Group Treatment : include peripheral nerve single injection catheter infusion ( 48 hour ) ; preoperative ( single dose ) intravenous acetaminophen ( 1000 mg ) intraoperative spinal anesthesia general anesthesia determine anesthesia attend physician ; postoperative oral oxycodone acetaminophen ( PRN dose ) , intravenous hydromorphone ( PRN dose ) breakthrough pain . IVAM Group Treatment : include peripheral nerve single injection catheter infusion ( 48 hour ) ; preoperative intravenous acetaminophen ( 1000 mg ) orphenadrine ( 60 mg ) ; intraoperative spinal anesthesia general anesthesia determine anesthesia attend physician ; postoperative intravenous acetaminophen ( 1000 mg ) every 6 hour routine total 8 dos intravenous orphenadrine ( 60 mg ) every 12 hour total 4 dos ; oral oxycodone ( 5 mg ) ( PRN dose ) , intravenous hydromorphone ( PRN dose ) breakthrough pain .</detailed_description>
	<mesh_term>Muscle Hypotonia</mesh_term>
	<mesh_term>Orphenadrine</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1 . Age 1885 2 . Primary , unilateral total knee arthroplasty 3 . American Society Anesthesiologist ( ASA ) physical status I , II , III 1 . Chronic pain ( determine regular opioid use month precede surgery ) 2 . Preoperative use centrally act muscle relaxant 24 hour precede surgery 3 . Peripheral regional anesthesia procedure femoral nerve injection catheter postoperative pain control ( popliteal block ) 4 . Severe renal dysfunction , creatinine &gt; 2.0 5 . Allergy contraindication use orphenadrine and/or acetaminophen 6 . Pregnant breast feed 7 . Abnormal Liver Function Tests ( LFT ) / history chronic/excessive alcohol abuse . 8 . History Hepatitis , B C , 9 . History cirrhosis hepatic insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>